The conference encompasses the entire biologics value chain, covering areas such as antibody therapies, cell and gene therapies, immunotherapies, and biosimilars. Attendees can engage in over 13 tracks of content, featuring 350 world-class speakers, 150 exhibitors, and 100 start-ups.
Key Themes:
Discovery & Development: Protein expression, target identification, lead screening, and AI-driven discovery.
Clinical Trials & Manufacturing: Translational medicine, clinical trial operations, bioprocessing, and fill/finish logistics.
Therapies & Disease Areas: Focus on oncology, autoimmune diseases, infectious diseases, and neurodegenerative disorders.
Commercialization & Market Access: Strategies for bringing biologic therapies to market effectively.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze